Report Detail
Global Remicade (infliximab) Drug Market Research Report 2019
- RnM3041977 |
- 28 February, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Other
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
The global Remicade (infliximab) Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Remicade (infliximab) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Remicade (infliximab) Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Brands Drugs
Generic Drugs
Segment by Application
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other
Table of Contents
Executive Summary
1 Remicade (infliximab) Drug Market Overview
- 1.1 Product Overview and Scope of Remicade (infliximab) Drug
- 1.2 Remicade (infliximab) Drug Segment by Type
- 1.2.1 Global Remicade (infliximab) Drug Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Brands Drugs
- 1.2.3 Generic Drugs
- 1.3 Remicade (infliximab) Drug Segment by Application
- 1.3.1 Remicade (infliximab) Drug Consumption Comparison by Application (2014-2025)
- 1.3.2 Crohn's Disease
- 1.3.3 Pediatric Crohn's Disease
- 1.3.4 Ulcerative Colitis
- 1.3.5 Pediatric Ulcerative Colitis
- 1.3.6 Other
- 1.4 Global Remicade (infliximab) Drug Market by Region
- 1.4.1 Global Remicade (infliximab) Drug Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Remicade (infliximab) Drug Market Size
- 1.5.1 Global Remicade (infliximab) Drug Revenue (2014-2025)
- 1.5.2 Global Remicade (infliximab) Drug Production (2014-2025)
2 Global Remicade (infliximab) Drug Market Competition by Manufacturers
- 2.1 Global Remicade (infliximab) Drug Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Remicade (infliximab) Drug Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Remicade (infliximab) Drug Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Remicade (infliximab) Drug Production Sites, Area Served, Product Types
- 2.5 Remicade (infliximab) Drug Market Competitive Situation and Trends
- 2.5.1 Remicade (infliximab) Drug Market Concentration Rate
- 2.5.2 Remicade (infliximab) Drug Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Remicade (infliximab) Drug Production Market Share by Regions
- 3.1 Global Remicade (infliximab) Drug Production Market Share by Regions
- 3.2 Global Remicade (infliximab) Drug Revenue Market Share by Regions (2014-2019)
- 3.3 Global Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Remicade (infliximab) Drug Production
- 3.4.1 North America Remicade (infliximab) Drug Production Growth Rate (2014-2019)
- 3.4.2 North America Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Remicade (infliximab) Drug Production
- 3.5.1 Europe Remicade (infliximab) Drug Production Growth Rate (2014-2019)
- 3.5.2 Europe Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Remicade (infliximab) Drug Production (2014-2019)
- 3.6.1 China Remicade (infliximab) Drug Production Growth Rate (2014-2019)
- 3.6.2 China Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Remicade (infliximab) Drug Production (2014-2019)
- 3.7.1 Japan Remicade (infliximab) Drug Production Growth Rate (2014-2019)
- 3.7.2 Japan Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Remicade (infliximab) Drug Consumption by Regions
- 4.1 Global Remicade (infliximab) Drug Consumption by Regions
- 4.2 North America Remicade (infliximab) Drug Consumption (2014-2019)
- 4.3 Europe Remicade (infliximab) Drug Consumption (2014-2019)
- 4.4 China Remicade (infliximab) Drug Consumption (2014-2019)
- 4.5 Japan Remicade (infliximab) Drug Consumption (2014-2019)
5 Global Remicade (infliximab) Drug Production, Revenue, Price Trend by Type
- 5.1 Global Remicade (infliximab) Drug Production Market Share by Type (2014-2019)
- 5.2 Global Remicade (infliximab) Drug Revenue Market Share by Type (2014-2019)
- 5.3 Global Remicade (infliximab) Drug Price by Type (2014-2019)
- 5.4 Global Remicade (infliximab) Drug Production Growth by Type (2014-2019)
6 Global Remicade (infliximab) Drug Market Analysis by Applications
- 6.1 Global Remicade (infliximab) Drug Consumption Market Share by Application (2014-2019)
- 6.2 Global Remicade (infliximab) Drug Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Remicade (infliximab) Drug Business
- 7.1 Janssen
- 7.1.1 Janssen Remicade (infliximab) Drug Production Sites and Area Served
- 7.1.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
- 7.1.3 Janssen Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Hospira
- 7.2.1 Hospira Remicade (infliximab) Drug Production Sites and Area Served
- 7.2.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
- 7.2.3 Hospira Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Celltrion Healthcare
- 7.3.1 Celltrion Healthcare Remicade (infliximab) Drug Production Sites and Area Served
- 7.3.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
- 7.3.3 Celltrion Healthcare Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Epirus Biopharmaceuticals
- 7.4.1 Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Sites and Area Served
- 7.4.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
- 7.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Samsung Bioepsis
- 7.5.1 Samsung Bioepsis Remicade (infliximab) Drug Production Sites and Area Served
- 7.5.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
- 7.5.3 Samsung Bioepsis Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
8 Remicade (infliximab) Drug Manufacturing Cost Analysis
- 8.1 Remicade (infliximab) Drug Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Remicade (infliximab) Drug
- 8.4 Remicade (infliximab) Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Remicade (infliximab) Drug Distributors List
- 9.3 Remicade (infliximab) Drug Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Remicade (infliximab) Drug Market Forecast
- 11.1 Global Remicade (infliximab) Drug Production, Revenue Forecast
- 11.1.1 Global Remicade (infliximab) Drug Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Remicade (infliximab) Drug Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Remicade (infliximab) Drug Price and Trend Forecast (2019-2025)
- 11.2 Global Remicade (infliximab) Drug Production Forecast by Regions (2019-2025)
- 11.2.1 North America Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
- 11.2.3 China Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
- 11.3 Global Remicade (infliximab) Drug Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Remicade (infliximab) Drug Consumption Forecast (2019-2025)
- 11.3.2 Europe Remicade (infliximab) Drug Consumption Forecast (2019-2025)
- 11.3.3 China Remicade (infliximab) Drug Consumption Forecast (2019-2025)
- 11.3.4 Japan Remicade (infliximab) Drug Consumption Forecast (2019-2025)
- 11.4 Global Remicade (infliximab) Drug Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Remicade (infliximab) Drug Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Remicade (infliximab) Drug . Industry analysis & Market Report on Remicade (infliximab) Drug is a syndicated market report, published as Global Remicade (infliximab) Drug Market Research Report 2019. It is complete Research Study and Industry Analysis of Remicade (infliximab) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
